Day 2
Day 2- 16 Mar 2022
|
9.45 – 9.50 am (5 mins) |
Housekeeping by Emcee
|
|
9.50 – 10.00 am (10 mins)
|
Corporate videos
|
|
10.00 – 10.25 am (25 mins) |
Biocrime - An Intentional Threat
Dr. Badrul Hisham Abd. Samad Academy of Professors Malaysia
|
|
10.25 - 10.50 am (25 mins)
|
The societal dimension of emerging vector-borne diseases
Prof Tri Baskoro Tunggul Satoto Gadja Mada University, Indonesia
|
|
10.50 - 11.15 am (25 mins) |
Leptospirosis in Malaysia
Dr. Hani Mat Hussin Ministry of Health, Malaysia
|
|
11.15 - 11.35 am
|
Break (20 minutes) |
|
11.35 - 12:00 pm (25 mins)
|
One health approach in tackling AMR: Malaysian perspective
Prof. Dr. Syafinaz Amin Nordin Universiti Putra Malaysia, Malaysia
|
|
12.00 – 12.25 pm (25 mins) |
Disseminated nontuberculous mycobacterial infection associated with anti-interferon gamma autoantibodies: another emerging infectious disease in Asia
Prof. Dr. Yupin Suputtamongkol Mahidol University, Thailand
|
|
12.25 - 12:50 pm (25 mins)
|
Transmission dynamics of Dengue in Asia
Dr. Harapan Unversitas Syiah Kuala, Indonesia
|
|
12.50 - 2:00 pm |
Lunch Break (70 mins) |
|
2.00 - 2.40 pm (40 mins) |
Plenary (SARS-CoV-2 variants) The ASAIHL Mundus and DYNAMEID Master programs
Prof. Dr. Roger Frutos CIRAD-University of Montpellier, France
|
|
2.40 - 3.05 pm (25 mins) |
One million dollars question
Associate Prof. Dr. Malina Osman Universiti Putra Malaysia, Malaysia
|
|
3.05 - 3.30 pm (25 mins) |
SARS-CoV-2 Local studies: What does it show?
Dr. Petrick Periyasamy Hospital Universiti Kebangsaan Malaysia (HUKM)
|
|
3.30 - 3:55 pm (25 mins)
|
Structural dynamics of SARS-CoV-2 variants
Prof. Dr. Jacques Fantini ‘Institut Universitaire de France
|
|
3.55 - 4.15 pm |
Break (20 mins) |
|
4.15 - 4.55 pm (40 mins) |
Plenary (Antimicrobial Resistance)
COVID-19: Collateral Damage or Collateral Benefit to AMR?
Prof. Dr. Sabiha Essack University of KwaZulu-Natal, South Africa
|
|
4.55 - 5.20 pm (25 mins)
|
The antifungal resistance challenges of 2022 and beyond
Prof. Dr. David W. Denning University of Manchester, UK
|
|
5.20 - 5.45 pm (25 mins)
|
Are we underestimating or overestimating the burden of AMR? Evidence from Southeast Asia
Associate Prof. Dr. Direk Limmathurotsakul
|
|
5.45 - 6.10 pm (25 min)
|
"LEMiMo´s role in the difficult task to tackle antimicrobial resistance"
Prof. Dr. Ilana L. B. C. Camargo Universidade de São Paulo, Brazil
|
|
6.10 - 6.20 pm (10 mins) |
Closing for ASAIHL Conference Prof. Dr. Zamberi Sekawi Dean, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
|